Cutaneous side effects of combined therapy with sorafenib and pegylated interferon alpha-2b in metastatic melanoma (phase II DeCOG trial)-Reference-Cited by-同舟云学术

Cutaneous side effects of combined therapy with sorafenib and pegylated interferon alpha-2b in metastatic melanoma (phase II DeCOG trial)

Published:2013-07-23 Issue:9 Volume:11 Page:846-853
ISSN:1610-0379
Container-title:JDDG: Journal der Deutschen Dermatologischen Gesellschaft
language:en
Short-container-title:JDDG: Journal der Deutschen Dermatologischen Gesellschaft

Author:

Degen Annette¹,Weichenthal Michael²,Ugurel Selma,Trefzer Uwe³,Kilian Katharina⁴,Garbe Claus⁵,Egberts Friederike²,Poppe Lìdia Marilia⁶,Hauschild Axel²,Gutzmer Ralf¹

Affiliation:

1. Department of Dermatology and Allergology, Hannover Medical School; Germany

2. Clinic for Dermatology, Venereology and Allergology, University Clinic Schleswig-Holstein; Campus Kiel; Germany

3. Clinic for Dermatology, Venereology and Allergology, Charité -; University Medicine Berlin; Germany

4. Clinic and Polyclinic for Dermatology and Allergology, University Clinic Munich (LMU); Germany

5. University Clinic for Dermatology; Tübingen; Germany

6. Clinic and Polyclinic for Dermatology, Venereology and Allergology; University Clinic Würzburg; Germany

Publisher

Wiley

Subject

Dermatology

Reference30 articles.

1. Side effects of systemic oncological therapies in dermatology;Zimmer;J Dtsch Dermatol Ges,2012

2. Fachinformation Nexavar Oktober 2011

3. Phase I clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors;Strumberg;J Clin Oncol,2005

4. Dermatologic symptoms associated with the multikinase inhibitor sorafenib;Robert;J Am Acad Dermatol,2009

5. Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial;Eggermont;Lancet,2008

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review of sex and gender differences in treatment outcome of inflammatory skin diseases: Is it time for new guidelines?;Journal of the European Academy of Dermatology and Venereology;2024-07-30

2. 5-Methoxytryptophan enhances the sensitivity of sorafenib on the inhibition of proliferation and metastasis for lung cancer cells;BMC Cancer;2024-02-22

3. The Impact of Immunological Checkpoint Inhibitors and Targeted Therapy on Chronic Pruritus in Cancer Patients;Biomedicines;2020-12-22

4. Evidence- and consensus-based recommendations for the use of pegvaliase in adults with phenylketonuria;Genetics in Medicine;2019-08

5. Brimonidine tartrate 0.33 % gel for the prevention and management of hand‐foot syndrome;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2019-03-28